Systemic lupus erythematosus in children and adolescents;Systemischer lupus erythematodes im kindes- und jugendalter

Zeitschrift fur Rheumatologie

Volumn 65, Issue 7, 2006, Pages 576-586

  Sallmann, S ^a   Fiebig, B ^a   Hedrich, C M ^a   Heubner, G ^b   Gahr, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Weißeritztal Kliniken GmbH Freital Dippoldiswalde   (Germany)

Author keywords

Childhood and adolescence; Clinical manifestations; Pathogenesis; SLE

Indexed keywords

CALCIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEW DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RITUXIMAB; STEROID; VITAMIN D;

ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; GENETIC SUSCEPTIBILITY; GONADAL DISEASE; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LABORATORY TEST; OSTEOPOROSIS; PATHOGENESIS; PHOTOTHERAPY; REPRODUCTIVE TOXICITY; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTINUCLEAR; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 33845434857     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0115-7     Document Type: Article

References (30)

1. Bader-Meunier B, Armengaud JB, Haddad E et al. (2005) Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146: 648-653
2. Bykerk V, Sampalis J, Esdaile JM et al. (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324: 150-154
3. Cameron JS (1994) Lupus nephritis in childhood and adolescence. Pediatr Nephrol 8: 230-249
4. Cassidy JT (1999) Osteopenia and osteoporosis in children. Clin Exp Rheumatol 17: 245-250
5. Chan TM, Li FK, Tang CS et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343: 1156-1162
6. Contreras G, Pardo V, Leclercq B et al. (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350: 971-980
7. Font J, Cervera R, Espinosa G et al. (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological finding in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57: 456-459
8. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V et al. (2001) Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 28: 761-765
9. Gutierrez-Suarez R, Ruperto N, Gastaldi R et al. (2006) A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index. Based on the analysis of 1.015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 54: 2989-2996
10. Harel L, Sandborg C, Lee T, Scheven E (2006) Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 33: 1873-1877
11. Hiraki L, Schneider R, Hebert D et al. (2004) Presentation of pediatric systemic lupus erythematosus: clinical and laboratory features. J Rheumatol 31: 1427-1432
12. Hochberg MC (1997) Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725
13. Howard LM, Kohm AP, Castañeda CL, Miller SD (2005) Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease. Curr Drug Targets Inflamm Allergy 4: 205-216
14. Isenberg DA (2006) B cell targeted therapies in autoimmune diseases. J Rheumatol 33 Suppl 77: 24-28
15. Kavanaugh A, Adams-Huet B, Jain R et al. (1997) Hydroxychloroquine effects on lipoprotein profiles (the HELP trial): a double-blind, randomized, placebo-controlled, pilot study in patients with sysemic lupus erythematosus. J Clin Rheumatol 3: 3-8
16. Lehman TJ, McCurdy DK, Bernstein BH et al. (1989) Systemic lupus erythematosus in the first decade of life. Pediatrics 83: 235-239
17. Lilleby V, Lien G, Frey Frøslie K et al. (2005) Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 52: 2051-2059
18. Male C, Foulon D, Hoogendoorn H et al. (2005) Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106: 4152-4158
19. Naveau C, Houssiau FA (2005) Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 14: 903-906
20. Perfumo F, Martini A (2005) Lupus nephritis in children. Lupus 14: 83-88
21. Petty RE, Cassidy JT (2001) Systemic lupus erythematosus. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 4th edn. WB Saunders, Philadelphia, pp 396-449
22. Pickering MC, Walport MJ (2000) Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 39: 133-141
23. Sarkissian T, Beyenne J, Feldman B et al. (2006) The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus. Arthritis Rheum 54: 1283-1290
24. Schmugge M, Revel-Vilk S, Hiraki L et al. (2003) Thrombozytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 143: 666-669
25. Shoenfeld Y, Gerli R, Doria A et al. (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337-3347
26. Sibbitt WL Jr, Brandt JR, Johnson CR et al. (2002) The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29: 1536-1542
27. Stichweh D, Arce E, Pascual V (2004) Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16: 577-587
28. Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277
29. Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34: 866-872
30. Willems M, Haddad E, Niaudet P et al. (2006) Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 148: 623-627